BofA Securities analyst Jason Gerberry reiterated a Neutral rating and $4.00 price target on ProKidney Corp. (NASDAQ: PROK).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE